AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/117
TREMENDOUS OUTBURST AMPLITUDE DWARF NOVAE
Authors: HOWELL SB SZKODY P CANNIZZO JK
Citation: Sb. Howell et al., TREMENDOUS OUTBURST AMPLITUDE DWARF NOVAE, The Astrophysical journal, 439(1), 1995, pp. 337-345
THE EUVE OPTICAL-IDENTIFICATION CAMPAIGN-II - LATE-TYPE AND WHITE-DWARF STARS
Authors: CRAIG N FRUSCIONE A DUPUIS J MATHIOUDAKIS M DRAKE JJ ABBOTT M CHRISTIAN C GREEN R BOROSON T HOWELL SB
Citation: N. Craig et al., THE EUVE OPTICAL-IDENTIFICATION CAMPAIGN-II - LATE-TYPE AND WHITE-DWARF STARS, The Astronomical journal, 110(3), 1995, pp. 1304-1315
PHARMACOKINETICS OF INTRALUMBAR DTC-101 FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES
Authors: CHAMBERLAIN MC KORMANIK P HOWELL SB KIM S
Citation: Mc. Chamberlain et al., PHARMACOKINETICS OF INTRALUMBAR DTC-101 FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES, Archives of neurology, 52(9), 1995, pp. 912-917
ASSOCIATION BETWEEN HSP60 MESSENGER-RNA LEVELS AND CISPLATIN RESISTANCE IN HUMAN HEAD AND NECK-CANCER CELL-LINES
Authors: NAKATA B BARTON RM ROBBINS KT HOWELL SB LOS G
Citation: B. Nakata et al., ASSOCIATION BETWEEN HSP60 MESSENGER-RNA LEVELS AND CISPLATIN RESISTANCE IN HUMAN HEAD AND NECK-CANCER CELL-LINES, International journal of oncology, 5(6), 1994, pp. 1425-1432
ANTIBODY TO HER-2 NEU RECEPTOR BLOCKS DNA-REPAIR AFTER CISPLATIN IN HUMAN BREAST AND OVARIAN-CANCER CELLS/
Authors: PIETRAS RJ FENDLY BM CHAZIN VR PEGRAM MD HOWELL SB SLAMON DJ
Citation: Rj. Pietras et al., ANTIBODY TO HER-2 NEU RECEPTOR BLOCKS DNA-REPAIR AFTER CISPLATIN IN HUMAN BREAST AND OVARIAN-CANCER CELLS/, Oncogene, 9(7), 1994, pp. 1829-1838
PHASE-I STUDY OF HIGHLY SELECTIVE SUPRADOSE CISPLATIN INFUSIONS FOR ADVANCED HEAD AND NECK-CANCER
Authors: ROBBINS KT STORNIOLO AM KERBER C VICARIO D SEAGREN S SHEA M HANCHETT C LOS G HOWELL SB
Citation: Kt. Robbins et al., PHASE-I STUDY OF HIGHLY SELECTIVE SUPRADOSE CISPLATIN INFUSIONS FOR ADVANCED HEAD AND NECK-CANCER, Journal of clinical oncology, 12(10), 1994, pp. 2113-2120
INDUCTION OF GADD153 PROMOTER ACTIVITY BY DDP AND TAXOL PROCEEDS THROUGH SEPARATE PATHWAYS
Authors: GATELY DP HOWELL SB
Citation: Dp. Gately et Sb. Howell, INDUCTION OF GADD153 PROMOTER ACTIVITY BY DDP AND TAXOL PROCEEDS THROUGH SEPARATE PATHWAYS, Journal of cellular biochemistry, 1994, pp. 101-101
ENHANCEMENT OF THE CYTOTOXICITY OF CISPLATIN BY THE CHOLECYSTOKININ ANTAGONIST MK-329 IN A HUMAN PANCREATIC-CANCER CELL-LINE
Authors: JAMSHIDIPOUR R PINHO EB HOM DK HOWELL SB
Citation: R. Jamshidipour et al., ENHANCEMENT OF THE CYTOTOXICITY OF CISPLATIN BY THE CHOLECYSTOKININ ANTAGONIST MK-329 IN A HUMAN PANCREATIC-CANCER CELL-LINE, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 484-490
IN-VIVO MODULATION OF CISPLATIN CYTOTOXICITY BY THE CHOLECYSTOKININ ANTAGONIST MK-329 IN HUMAN PANCREATIC-CANCER XENOGRAFTS
Authors: JAMSHIDIPOUR R PINHO EB HOWELL SB
Citation: R. Jamshidipour et al., IN-VIVO MODULATION OF CISPLATIN CYTOTOXICITY BY THE CHOLECYSTOKININ ANTAGONIST MK-329 IN HUMAN PANCREATIC-CANCER XENOGRAFTS, Anticancer research, 14(6B), 1994, pp. 2611-2616
SIGNALING AND DRUG-SENSITIVITY
Authors: CHRISTEN RD ISONISHI S JONES JA JEKUNEN AP HOM DK KRONING R GATELY DP THIEBAUT FB LOS G HOWELL SB
Citation: Rd. Christen et al., SIGNALING AND DRUG-SENSITIVITY, Cancer metastasis reviews, 13(2), 1994, pp. 175-189
A COMPARISON OF INTRAVENOUS VERSUS INTRAPERITONEAL CHEMOTHERAPY FOR THE INITIAL TREATMENT OF OVARIAN-CANCER
Authors: KIRMANI S BRALY PS MCCLAY EF SALTZSTEIN SL PLAXE SC KIM S CATES C HOWELL SB
Citation: S. Kirmani et al., A COMPARISON OF INTRAVENOUS VERSUS INTRAPERITONEAL CHEMOTHERAPY FOR THE INITIAL TREATMENT OF OVARIAN-CANCER, Gynecologic oncology, 54(3), 1994, pp. 338-344
CONTEMPORARY-ISSUES IN TOXICOLOGY - ROLE OF METALLOTHIONEIN IN CARCINOGENESIS
Authors: CHERIAN MG HOWELL SB IMURA N KLAASSEN CD KOROPATNICK J LAZO JS WAALKES MP
Citation: Mg. Cherian et al., CONTEMPORARY-ISSUES IN TOXICOLOGY - ROLE OF METALLOTHIONEIN IN CARCINOGENESIS, Toxicology and applied pharmacology, 126(1), 1994, pp. 1-5
CISPLATIN SENSITIVITY CORRELATES WITH ITS ABILITY TO CAUSE CELL-CYCLEARREST VIA A WEE1 KINASE-DEPENDENT PATHWAY IN SCHIZOSACCHAROMYCES-POMBE
Authors: THIEBAUT F ENNS R HOWELL SB
Citation: F. Thiebaut et al., CISPLATIN SENSITIVITY CORRELATES WITH ITS ABILITY TO CAUSE CELL-CYCLEARREST VIA A WEE1 KINASE-DEPENDENT PATHWAY IN SCHIZOSACCHAROMYCES-POMBE, Journal of cellular physiology, 159(3), 1994, pp. 506-514
CROSS-RESISTANCE BETWEEN CISPLATIN AND ANTIMONY IN A HUMAN OVARIAN-CARCINOMA CELL-LINE
Authors: NAREDI P HEATH DD ENNS RE HOWELL SB
Citation: P. Naredi et al., CROSS-RESISTANCE BETWEEN CISPLATIN AND ANTIMONY IN A HUMAN OVARIAN-CARCINOMA CELL-LINE, Cancer research, 54(24), 1994, pp. 6464-6468
CELLULAR PHARMACOLOGY OF DICHLORO(ETHYLENEDIAMINE) PLATINUM(II) IN CISPLATIN-SENSITIVE AND RESISTANT HUMAN OVARIAN-CARCINOMA CELLS
Authors: JEKUNEN AP HOM DK ALCARAZ JE EASTMAN A HOWELL SB
Citation: Ap. Jekunen et al., CELLULAR PHARMACOLOGY OF DICHLORO(ETHYLENEDIAMINE) PLATINUM(II) IN CISPLATIN-SENSITIVE AND RESISTANT HUMAN OVARIAN-CARCINOMA CELLS, Cancer research, 54(10), 1994, pp. 2680-2687
A PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITHINTRAABDOMINAL MALIGNANCIES
Authors: MCCLAY EF BRALY PD KIRMANI S PLAXE SC MCCLAY ME WILGUS L KIM S HOWELL SB
Citation: Ef. Mcclay et al., A PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITHINTRAABDOMINAL MALIGNANCIES, Cancer, 74(2), 1994, pp. 664-669
INDUCTION OF THE GROWTH ARREST AND DNA DAMAGE-INDUCIBLE GENE GADD153 BY CISPLATIN IN-VITRO AND IN-VIVO
Authors: GATELY DP JONES JA CHRISTEN R BARTON RM LOS G HOWELL SB
Citation: Dp. Gately et al., INDUCTION OF THE GROWTH ARREST AND DNA DAMAGE-INDUCIBLE GENE GADD153 BY CISPLATIN IN-VITRO AND IN-VIVO, British Journal of Cancer, 70(6), 1994, pp. 1102-1106
TAMOXIFEN DELAYS THE DEVELOPMENT OF RESISTANCE TO CISPLATIN IN HUMAN-MELANOMA AND OVARIAN-CANCER CELL-LINES
Authors: MCCLAY EF ALBRIGHT KD JONES JA CHRISTEN RD HOWELL SB
Citation: Ef. Mcclay et al., TAMOXIFEN DELAYS THE DEVELOPMENT OF RESISTANCE TO CISPLATIN IN HUMAN-MELANOMA AND OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 70(3), 1994, pp. 449-452
ENHANCEMENT OF SENSITIVITY TO PLATINUM(II)-CONTAINING DRUGS BY 12-O-TETRADECANOYL-PHORBOL-13-ACETATE IN A HUMAN OVARIAN-CARCINOMA CELL-LINE
Authors: ISONISHI S HOM DK EASTMAN A HOWELL SB
Citation: S. Isonishi et al., ENHANCEMENT OF SENSITIVITY TO PLATINUM(II)-CONTAINING DRUGS BY 12-O-TETRADECANOYL-PHORBOL-13-ACETATE IN A HUMAN OVARIAN-CARCINOMA CELL-LINE, British Journal of Cancer, 69(2), 1994, pp. 217-221
SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND TAXOL IN HUMAN OVARIAN-CARCINOMA CELLS IN-VITRO
Authors: JEKUNEN AP CHRISTEN RD SHALINSKY DR HOWELL SB
Citation: Ap. Jekunen et al., SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND TAXOL IN HUMAN OVARIAN-CARCINOMA CELLS IN-VITRO, British Journal of Cancer, 69(2), 1994, pp. 299-306
ROSAT OBSERVATIONS OF THE BLACK-HOLE CANDIDATE V404 CYGNI IN QUIESCENCE
Authors: WAGNER RM STARRFIELD SG HJELLMING RM HOWELL SB KREIDL TJ
Citation: Rm. Wagner et al., ROSAT OBSERVATIONS OF THE BLACK-HOLE CANDIDATE V404 CYGNI IN QUIESCENCE, The Astrophysical journal, 429(1), 1994, pp. 120000025-120000028
A BROAD OBSERVATIONAL STUDY OF THE ECLIPSING MAGNETIC CATACLYSMIC VARIABLE RE-2107-05
Authors: GLENN J HOWELL SB SCHMIDT GD LIEBERT J GRAUER AD WAGNER RM
Citation: J. Glenn et al., A BROAD OBSERVATIONAL STUDY OF THE ECLIPSING MAGNETIC CATACLYSMIC VARIABLE RE-2107-05, The Astrophysical journal, 424(2), 1994, pp. 967-975
A TARGETED SUPRADOSE CISPLATIN CHEMORADIATION PROTOCOL FOR ADVANCED HEAD AND NECK-CANCER
Authors: ROBBINS KT VICARIO D SEAGREN S WEISMAN R PELLITTERI P KERBER C ORLOFF L LOS G HOWELL SB
Citation: Kt. Robbins et al., A TARGETED SUPRADOSE CISPLATIN CHEMORADIATION PROTOCOL FOR ADVANCED HEAD AND NECK-CANCER, The American journal of surgery, 168(5), 1994, pp. 419-422
CORRELATION OF THE SURVIVAL OF OVARIAN-CANCER PATIENTS WITH MESSENGER-RNA EXPRESSION OF THE 60-KD HEAT-SHOCK PROTEIN HSP-60
Authors: KIMURA E ENNS RE ALCARAZ JE ARBOLEDA J SLAMON DJ HOWELL SB
Citation: E. Kimura et al., CORRELATION OF THE SURVIVAL OF OVARIAN-CANCER PATIENTS WITH MESSENGER-RNA EXPRESSION OF THE 60-KD HEAT-SHOCK PROTEIN HSP-60, Journal of clinical oncology, 11(5), 1993, pp. 891-898
PHASE-I PHARMACOKINETIC STUDY OF HIGH-DOSE PROGESTERONE AND DOXORUBICIN
Authors: CHRISTEN RD MCCLAY EF PLAXE SC YEN SSC KIM S KIRMANI S WILGUS LL HEATH DD SHALINSKY DR FREDDO JL BRALY PS OQUIGLEY J HOWELL SB
Citation: Rd. Christen et al., PHASE-I PHARMACOKINETIC STUDY OF HIGH-DOSE PROGESTERONE AND DOXORUBICIN, Journal of clinical oncology, 11(12), 1993, pp. 2417-2426
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>